EXVASTAT

Exvastat is an innovative, preclinical-stage pharmaceutical company founded in 2016. The company is developing a treatment for acute respiratory distress syndrome (ARDS) based on a repurposed drug which is marketed worldwide for other indications. The new treatment has the potential to significantly reduce the high mortality and incapacitating morbidities caused by ARDS, as well as the costs of caring for these critically ill patients to health service providers.

#People #Financial #Website #More

EXVASTAT

Social Links:

Twitter

Industry:

Biotechnology Health Care Life Science Medical Pharmaceutical

Founded:

2016-01-01

Address:

Cambridge, Cambridgeshire, United Kingdom

Country:

United Kingdom

Website Url:

http://www.exvastat.com

Total Employee:

Status:

Active

Email Addresses:

[email protected]

Total Funding:

3.9 M USD

Technology used in webpage:

SPF Euro Microsoft Exchange Online Office 365 Mail Google Apps For Business Cloudflare JS CDN JS Pexels Twitter CDN WordPress 5.5

Current Advisors List

robert-tansley_image

Robert Tansley Board Member @ Exvastat
Board_member
2017-01-01

Current Employees Featured

robert-tansley_image

Robert Tansley
Robert Tansley Chairperson @ Exvastat
Chairperson
2017-01-01

andrew-mcelroy_image

Andrew McElroy
Andrew McElroy Co-Founder & Strategic Project Manager @ Exvastat
Co-Founder & Strategic Project Manager
2016-05-01

julian-gilbert_image

Julian Gilbert
Julian Gilbert Non Executive Director @ Exvastat
Non Executive Director
2021-04-01

david-cavalla_image

David Cavalla
David Cavalla Co-Founder, Chief Executive Officer & Executive Director @ Exvastat
Co-Founder, Chief Executive Officer & Executive Director
2016-12-01

stuart-gibson_image